JP2013510169A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013510169A5 JP2013510169A5 JP2012538031A JP2012538031A JP2013510169A5 JP 2013510169 A5 JP2013510169 A5 JP 2013510169A5 JP 2012538031 A JP2012538031 A JP 2012538031A JP 2012538031 A JP2012538031 A JP 2012538031A JP 2013510169 A5 JP2013510169 A5 JP 2013510169A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- amount
- domain
- compound
- fusion protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 3
- 108020001507 fusion proteins Proteins 0.000 claims 3
- 102000037865 fusion proteins Human genes 0.000 claims 3
- 210000003097 mucus Anatomy 0.000 claims 3
- 229920002683 Glycosaminoglycan Polymers 0.000 claims 2
- 102000005348 Neuraminidase Human genes 0.000 claims 2
- 108010006232 Neuraminidase Proteins 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 150000001413 amino acids Chemical class 0.000 claims 2
- 230000003197 catalytic effect Effects 0.000 claims 2
- 210000002345 respiratory system Anatomy 0.000 claims 2
- 101000809450 Homo sapiens Amphiregulin Proteins 0.000 claims 1
- 102000043494 human AREG Human genes 0.000 claims 1
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US25903309P | 2009-11-06 | 2009-11-06 | |
| US25905509P | 2009-11-06 | 2009-11-06 | |
| US61/259,033 | 2009-11-06 | ||
| US61/259,055 | 2009-11-06 | ||
| US32281310P | 2010-04-09 | 2010-04-09 | |
| US61/322,813 | 2010-04-09 | ||
| US33206310P | 2010-05-06 | 2010-05-06 | |
| US61/332,063 | 2010-05-06 | ||
| US38142010P | 2010-09-09 | 2010-09-09 | |
| US61/381,420 | 2010-09-09 | ||
| PCT/US2010/055636 WO2011057081A1 (en) | 2009-11-06 | 2010-11-05 | Methods, compounds and compositions for treatment and prophylaxis in the respiratory tract |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2013510169A JP2013510169A (ja) | 2013-03-21 |
| JP2013510169A5 true JP2013510169A5 (enExample) | 2013-12-26 |
Family
ID=43970356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012538031A Pending JP2013510169A (ja) | 2009-11-06 | 2010-11-05 | 呼吸器管の治療及び予防のための方法、化合物、及び組成物 |
Country Status (8)
| Country | Link |
|---|---|
| US (6) | US8398971B2 (enExample) |
| EP (1) | EP2496251A4 (enExample) |
| JP (1) | JP2013510169A (enExample) |
| CN (1) | CN102711807A (enExample) |
| AU (1) | AU2010315024B2 (enExample) |
| CA (1) | CA2780193A1 (enExample) |
| IL (1) | IL219579B (enExample) |
| WO (1) | WO2011057081A1 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8512710B2 (en) | 2002-11-22 | 2013-08-20 | Ansun Biopharma, Inc. | Class of therapeutic protein based molecules |
| WO2011057081A1 (en) * | 2009-11-06 | 2011-05-12 | Nexbio, Inc. | Methods, compounds and compositions for treatment and prophylaxis in the respiratory tract |
| AU2013221230A1 (en) * | 2012-02-17 | 2014-10-02 | Ansun Biopharma, Inc. | Methods, compounds and compositions for treatment of parainfluenza virus in immunocompromised patients |
| EP2877204A2 (en) * | 2012-06-28 | 2015-06-03 | Ansun Biopharma, Inc. | Microparticle formulations for delivery to the upper and central respiratory tract and methods of manufacture |
| US20140099380A1 (en) | 2012-06-28 | 2014-04-10 | Ansun Biopharma, Inc. | Microparticle Formulations for Delivery to the Lower and Central Respiratory Tract and Methods of Manufacture |
| FR3022256B1 (fr) * | 2014-06-17 | 2018-03-09 | Adisseo France S.A.S. | Nouvelles souches d’arthrobacter gandavensis |
| ES2947312T3 (es) | 2016-07-01 | 2023-08-04 | Univ Leland Stanford Junior | Conjugados para la edición dirigida de la superficie celular |
| CN108926707B (zh) * | 2017-05-26 | 2021-12-03 | 中国医学科学院病原生物学研究所 | Pf4的抗rsv应用 |
| AU2019205912B2 (en) | 2018-01-03 | 2025-06-26 | Palleon Pharmaceuticals Inc. | Recombinant human sialidases, sialidase fusion proteins, and methods of using the same |
| CN109288114A (zh) * | 2018-10-08 | 2019-02-01 | 厦门艾赛生物科技有限公司 | 一种唾液酸及其衍生物的应用和唾液酸电子烟液 |
| AU2020301037A1 (en) * | 2019-07-03 | 2022-02-03 | Palleon Pharmaceuticals Inc. | Recombinant human sialidases, sialidase fusion proteins, and methods of using the same |
| BR112022019685A2 (pt) * | 2020-04-01 | 2022-11-22 | Lifescience As | Composições de ácido siálico para uso na inibição ou no tratamento de infecções por coronavírus |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7019A (en) * | 1850-01-15 | Improvement in obstetrical supporters | ||
| US8501911B2 (en) * | 1999-02-24 | 2013-08-06 | Biomarck Pharmaceuticals, Ltd | Methods of reducing inflammation and mucus hypersecretion |
| US7807174B2 (en) * | 2002-11-22 | 2010-10-05 | Nexbio, Inc. | Class of therapeutic protein based molecules |
| CA2932997C (en) * | 2006-01-24 | 2019-07-30 | Nexbio, Inc. | Technology for preparation of macromolecular microspheres |
| CN101848704A (zh) * | 2007-07-24 | 2010-09-29 | 耐百生物制药有限公司 | 用于制备微粒的技术 |
| JP2011507968A (ja) * | 2007-12-27 | 2011-03-10 | エイヤーズ ファーマシューティカルズ、インク． | エアロゾル化ニトライトおよび一酸化窒素供与性化合物ならびにそれらの使用 |
| WO2011057081A1 (en) * | 2009-11-06 | 2011-05-12 | Nexbio, Inc. | Methods, compounds and compositions for treatment and prophylaxis in the respiratory tract |
-
2010
- 2010-11-05 WO PCT/US2010/055636 patent/WO2011057081A1/en not_active Ceased
- 2010-11-05 EP EP10829154.3A patent/EP2496251A4/en not_active Withdrawn
- 2010-11-05 CA CA2780193A patent/CA2780193A1/en not_active Abandoned
- 2010-11-05 US US12/940,742 patent/US8398971B2/en active Active
- 2010-11-05 JP JP2012538031A patent/JP2013510169A/ja active Pending
- 2010-11-05 AU AU2010315024A patent/AU2010315024B2/en not_active Ceased
- 2010-11-05 CN CN2010800606702A patent/CN102711807A/zh active Pending
-
2012
- 2012-05-03 IL IL219579A patent/IL219579B/en active IP Right Grant
-
2013
- 2013-02-15 US US13/769,095 patent/US20130156703A1/en not_active Abandoned
-
2014
- 2014-09-17 US US14/489,428 patent/US20150017150A1/en not_active Abandoned
-
2016
- 2016-04-22 US US15/136,751 patent/US20160228518A1/en not_active Abandoned
-
2018
- 2018-01-08 US US15/865,217 patent/US20180140683A1/en not_active Abandoned
-
2020
- 2020-06-04 US US16/893,265 patent/US20200297822A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013510169A5 (enExample) | ||
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| JP2009537143A5 (enExample) | ||
| JP2011528896A5 (enExample) | ||
| MY157564A (en) | Combination pharmaceutical composition and methods of treating functional diseases or conditions of gastrointestinal tract | |
| WO2010062688A3 (en) | Dosage form for insertion into the mouth | |
| JP2011528895A5 (enExample) | ||
| JP2010202664A5 (enExample) | ||
| WO2010139808A3 (en) | Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hrsv) nanobody constructs for the prevention and/or treatment of respiratory tract infections | |
| JP2012500090A5 (enExample) | ||
| WO2007092563A3 (en) | Gene therapy for niemann-pick disease type a | |
| JP2009517473A5 (enExample) | ||
| JP2013127002A5 (enExample) | ||
| JP2014503593A5 (enExample) | ||
| JP2011528897A5 (enExample) | ||
| JP2013526392A5 (enExample) | ||
| WO2008063511A3 (en) | Methods for treating pompe disease | |
| UA107578C2 (uk) | Комбінована терапія при лікуванні діабету | |
| JP2011225596A5 (enExample) | ||
| MY153408A (en) | Novel methods | |
| WO2008135038A3 (de) | Diagnose und risikostratifizierung mittels nt-proet-1 | |
| JP2013503110A5 (enExample) | ||
| WO2010068754A3 (en) | Methods and compositions for delivery of medicaments to the lungs | |
| JP2014513722A5 (enExample) | ||
| MD4369B1 (ro) | Utilizarea glicopirolatului pentru tratarea tahicardiei, doză unică, dispozitiv de administrare, metodă de tratament şi profilaxie a tahicardiei |